October 06, 2025

Nearly 600 Advocates Unite in Washington for AOA on Capitol Hill 2025

The event provided for a unified, pro-patient message to policymakers

Optometric Management

September 15, 2025

ARCHER Study Supports at Least 15-Letter Loss as Meaningful Endpoint in Dry AMD With GA

Phase 2 results show vonaprument reduced the risk of significant visual decline compared with sham.

Retinal Physician

January 01, 2025

Importance of Early Identification of Geographic Atrophy and Treatment Recommendations

Discover how advancements in imaging technologies are enabling early identification of geographic atrophy (GA), critical for preserving vision and improving patient outcomes.

Optometric Management

February 13, 2025

FDA Approves Extended Label for Avacincaptad Pegol

The new label removes limitations on the duration of dosing.

Conexiant

January 16, 2025

LA County Fires Prompt Business Recovery Centers to Open

"Business owners can meet face-to-face with specialists to apply for disaster loans and access a wide range of resources to guide them through their recovery."

Optometric Management

May 19, 2025

Test Your Diagnostic Skills using OCT and Fundus Imaging

Test Your Diagnostic Skills using OCT and Fundus Imaging

The Ophthalmologist

July 16, 2025

AOA Advocates for Optometry in the One Big Beautiful Bill Act

Their successes, areas for continued monitoring, exclusions, and next steps

Optometric Management

June 19, 2024

Specialties With Highest Unprofessional Behavior Reports

A recent study reveals that surgeons are most frequently reported for unprofessional behavior by coworkers, while pediatric-focused physicians are least likely to be reported.

Conexiant

April 16, 2025

Biocon, Regeneron Reach Agreement on Eylea Biosimilar

The agreement clears the way for Yesafili, an FDA-approved aflibercept biosimilar, to be commercialized in the United States.

Retinal Physician